RiverVest Venture Fund IV L.P. 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-01 11:07 am Sale | 2022-11-11 | 13D | Mirum Pharmaceuticals, Inc. MIRM | RiverVest Venture Fund IV L.P. | 1,621,118 4.400% | -300,000 (-15.62%) | Filing |
| 2020-12-22 4:01 pm Unchanged | 2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM | RiverVest Venture Fund IV L.P. | 1,921,118 6.600% | 0 (Unchanged) | Filing |